(Q36871226)

16 August 2017

1 reference

title

Selectively infective phages (SIP). (English)

1 reference

16 August 2017

Spada S

1

1 reference

16 August 2017

Krebber C

series ordinal

2

1 reference

16 August 2017

Plückthun A

series ordinal

3

1 reference

16 August 2017

publication date

1 June 1997

1 reference

16 August 2017

1 reference

16 August 2017

volume

378

1 reference

16 August 2017

issue

6

1 reference

16 August 2017

page(s)

445-456

1 reference

Characterization of phage that bind plastic from phage-displayed random peptide libraries.

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

Gene identification using the yeast two-hybrid system

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

Nucleotide sequence and genome organisation of filamentous bacteriophages fl and fd.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

In vitro selection from protein and peptide libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

Display of biologically active proteins on the surface of filamentous phages: a cDNA cloning system for selection of functional gene products linked to the genetic information responsible for their production

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

Gene-III protein of filamentous phages: evidence for a carboxyl-terminal domain with a role in morphogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

Clonal Selection and Amplification of Phage Displayed Antibodies by Linking Antigen Recognition and Phage Replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

Novel helper phage design: intergenic region affects the assembly of bacteriophages and the size of antibody libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

In vitro immunization of naive human B cells yields high affinity immunoglobulin G antibodies as illustrated by phage display

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

Location of filamentous phage minor coat proteins in phage and in infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

The role of the adsorption complex in the termination of filamentous phage assembly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

Direct interaction rescue, a novel filamentous phage technique to study protein-protein interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

In vitro selection and evolution of functional proteins by using ribosome display

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

A conserved infection pathway for filamentous bacteriophages is suggested by the structure of the membrane penetration domain of the minor coat protein g3p from phage fd

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

Co-selection of cognate antibody-antigen pairs by selectively-infective phages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

Selectively-infective phage (SIP): a mechanistic dissection of a novel in vivo selection for protein-ligand interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

Morphogenesis of filamentous bacteriophage f1: orientation of extrusion and production of polyphage

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

Selecting high-affinity binding proteins by monovalent phage display

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

Phage antibodies: filamentous phage displaying antibody variable domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

Nucleotide sequence and genetic organization of the genome of the N-specific filamentous bacteriophage IKe. Comparison with the genome of the F-specific filamentous phages M13, fd and f1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

An efficient screening assay for the rapid and precise determination of affinities between leucine zipper domains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

Identification of D-peptide ligands through mirror-image phage display

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

Rapid evolution of a protein in vitro by DNA shuffling

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

Display of peptides and proteins on the surface of bacteriophage lambda

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

Human antibodies with sub-nanomolar affinities isolated from a large non-immunized phage display library

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

Trinucleotide phosphoramidites: ideal reagents for the synthesis of mixed oligonucleotides for random mutagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

The tol gene products and the import of macronmolecules into Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

Making antibodies by phage display technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

The retroviral vector. Replication cycle and safety considerations for retrovirus-mediated gene therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

Expression of human endogenous retrovirus (HERV-K) in chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

Molecular evolution. Retroposon revivals

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

Gene therapy of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

Measuring success in clinical gene therapy research

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

Origins and evolutionary relationships of retroviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

High fidelity DNA synthesis by the Thermus aquaticus DNA polymerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

The efficiency of cell targeting by recombinant retroviruses depends on the nature of the receptor and the composition of the artificial cell-virus linker

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

Retroviruses and transposons. Wandering retroviruses?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

Retroelements, reverse transcriptase and evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

The Role of Human Immunodeficiency Virus Type 1 Envelope Glycoproteins in Virus Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

Pseudotyped retroviral vectors for studies of human gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

Ligand-directed retroviral targeting of human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

Generation of competent virus in the REV helper cell line C3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

Genetic consequences of packaging two RNA genomes in one retroviral particle: pseudodiploidy and high rate of genetic recombination

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

Retroviral Recombination and Reverse Transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

Molecular biology of viral and nonviral retroelements

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

Retrovirus insertion into herpesviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

Tissue-specific targeting of retroviral vectors through ligand-receptor interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

Generation of diversity in retroviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

The challenge of follow-up for clinical trials of somatic gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

Creation of a processed pseudogene by retroviral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

The viruses in all of us: characteristics and biological significance of human endogenous retrovirus sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

Partial reconstitution of a replication-competent retrovirus in helper cells with partial overlaps between vector and helper cell genomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

Targeted infection of a retrovirus bearing a CD4-Env chimera into human cells expressing human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

Retrovirus packaging cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

Characterization of a replication-competent retrovirus resulting from recombination of packaging and vector sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

Broad spectrum of in vivo forward mutations, hypermutations, and mutational hotspots in a retroviral shuttle vector after a single replication cycle: deletions and deletions with insertions

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

Vectors and target cells for gene therapy of blood diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

Retrotransposons and the evolution of mammalian gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

A versatile and potentially general approach to the targeting of specific cell types by retroviruses: application to the infection of human cells by means of major histocompatibility complex class I and class II antigens by mouse ecotropic murine le

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

Retroviral vectors displaying functional antibody fragments

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

Generation of targeted retroviral vectors by using single-chain variable fragment: an approach to in vivo gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

Safety considerations in somatic gene therapy of human disease with retrovirus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

Retrovirus variation and reverse transcription: abnormal strand transfers result in retrovirus genetic variation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

HERV-K: the biologically most active human endogenous retrovirus family

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

Molecular Evolution: Unlocking the secrets of retroviral evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

Innovative developments in isotachophoresis (displacement electrophoresis).

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

Efficient incorporation of human CD4 protein into avian leukosis virus particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

Enhancement of hepatitis C virus NS3 proteinase activity by association with NS4A-specific synthetic peptides: identification of sequence and critical residues of NS4A for the cofactor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

Pretreatment virus load and multiple amino acid substitutions in the interferon sensitivity-determining region predict the outcome of interferon treatment in patients with chronic genotype 1b hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

Analysis of NS3-mediated processing of the hepatitis C virus non-structural region in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

A zinc binding site in viral serine proteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

Complete 5' noncoding region is necessary for the efficient internal initiation of hepatitis C virus RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

Characterization of RNA binding activity and RNA helicase activity of the hepatitis C virus NS3 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

Identification of the protease domain in NS3 of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

The interferon sensitivity determining region: all hepatitis C virus isolates are not the same

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

Proteolytic processing and membrane association of putative nonstructural proteins of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

Expression, isolation, and characterization of the hepatitis C virus ATPase/RNA helicase

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

Production of two phosphoproteins from the NS5A region of the hepatitis C viral genome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

Regulation of the interferon-induced PKR: can viruses cope?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

C-terminal domain of the hepatitis C virus NS3 protein contains an RNA helicase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

In vitro studies on the activation of the hepatitis C virus NS3 proteinase by the NS4A cofactor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

Analysis of genotypes and amino acid residues 2209 to 2248 of the NS5A region of hepatitis C virus in relation to the response to interferon-beta therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

Conservation and variability in the structures of serine proteinases of the chymotrypsin family

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

The hepatitis C virus NS3 serine proteinase and NS4A cofactor: establishment of a cell-free trans-processing assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

The crystal structure of hepatitis C virus NS3 proteinase reveals a trypsin-like fold and a structural zinc binding site

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

Production of nonstructural proteins of hepatitis C virus requires a putative viral protease encoded by NS3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

The 2A proteinase of human rhinovirus is a zinc containing enzyme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

A novel sequence found at the 3' terminus of hepatitis C virus genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

Identification of the domain required for trans-cleavage activity of hepatitis C viral serine proteinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

A central hydrophobic domain of the hepatitis C virus NS4A protein is necessary and sufficient for the activation of the NS3 protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

Spectroscopic characterization of rhinoviral protease 2A: Zn is essential for the structural integrity

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

Helicases: amino acid sequence comparisons and structure-function relationships

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

A new superfamily of putative NTP-binding domains encoded by genomes of small DNA and RNA viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM.1997.378.6.445

10.1515/BCHM.1997.378.6.445

21 January 2018

Identifiers

DOI

1 reference

16 August 2017

1 reference